Date | Programmes | Podcast Title | |
---|---|---|---|
09-Apr-25 |
Market Watch (7:00 AM) |
Stagflation Ahead For US Economy?
Carlos Casanova, Senior Economist, UBP |
|
03-Apr-25 |
Market Watch (7:00 AM) |
US Markets Nosediving On Tariff Thursday
Joe Quinlan, Chief Market Strategist, US Trust-BOA Private Wealth Management |
|
02-Apr-25 |
Market Watch (9:15 AM) |
Domestic Reasons To Stay Positive On Bursa Malaysia
Lim Sue Lin, Co-Head of Research, Maybank Investment Bank |
|
02-Apr-25 |
Market Watch (9:00 AM) |
Tariff Bad News Might be in the Price
Peter Lim, Chief Research Officer, Trident Analytics |
|
28-Mar-25 |
Market Watch (7:00 AM) |
Pick Your Sectors Carefully
Kelvin Wong, Senior Market Analyst, OANDA |
|
26-Mar-25 |
Market Watch (7:00 AM) |
No Contagion Effect On Asian Currencies
Carlos Casanova, Senior Economist, UBP |
|
25-Mar-25 |
Market Watch (7:00 AM) |
Potential US Recession Or Stagflation?
Jameel Ahmad, Chief Analyst, Online Trading Brokerage, GTC |
|
24-Mar-25 |
Market Watch (7:00 AM) |
The Switching Strategy Will Pay Off
Kingsley Jones, Chief Investment Officer, Jevons Global |
|
21-Mar-25 |
Market Watch (9:00 AM) |
Investors Cautious Over Tariff Uncertainty
Laurent Lequeu, Independent Market Analyst & Writer, The Macro Butler Newsletter |
|
20-Mar-25 |
Market Watch (7:00 AM) |
Is The Rate Cut Trajectory On Track?
Vishnu Varathan, Head of Economics & Strategy, Mizuho Bank |
|
19-Mar-25 |
Market Watch (7:00 AM) |
Higher Probability Of A US Recession
Yeap Jun Rong, Market Strategist, IG International |
|
17-Mar-25 |
Market Watch (7:00 AM) |
Market Rebound: Sustainable Or Short-Lived?
Brian Arcese, Portfolio Manager & Equity Analyst , Foord Asset Management |
|
12-Mar-25 |
Market Watch (7:00 AM) |
Reading The Tea Leaves to Determine A Recession
Song Seng Wun, Economic Advisor, CGS International Securities |
|
11-Mar-25 |
Market Watch (7:00 AM) |
US Markets Routed Amid Recession Fears
Tim Waterer, Chief Market Analyst, KCM Trade |
|
10-Mar-25 |
Market Watch (7:00 AM) |
European Defence Stocks Flying High
Kingsley Jones, Chief Investment Officer, Jevons Global |
|
07-Mar-25 |
Market Watch (7:00 AM) |
Markets Fatigued Over Neverending Tariff News
Tim Mulholland, President, TJM Limited, Chicago |
The 6AM Stretch
Thought-provoking discussions on ideas, people and events shaping our lives.
World Market Watch
Tony Nash of Complete Intelligence tells us where international markets are heading.
Morning Brief
We recap global and local headlines from today's papers and portals.
Morning Brief
Heron Lim, Economist at Moody’s Analytics discusses the impact of Trump's tariffs on China's economy.
Morning Brief
Prof. Azmi Hassan, Political Analyst and Senior Fellow at the Nusantara Academy weighs in on the three cornered fight in the Ayer Kuning By-election
The Breakfast Grille
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Morning Brief
Dr Renato Lima de Oliveira, Institute of Democracy and Economic Affairs (IDEAS) discusses the depletion of natural gas reserves in Malaysia.
Opening Bell
(REPEAT) Tony Nash of Complete Intelligence tells us where international markets are heading.
Opening Bell
Christopher Wong, FX Strategist at OCBC speaks about the impact of Trump’s tariffs on Asian currencies.
Ringgit & Sense
Jennifer Chua, licensed Financial Advisor at UOB Kay Hian talks about the ins and outs of planning for your parents' aged care.
Open For Business
How Nexacore Aims to Solve the ‘Last Mile’ Problem in Device Insurance
Tech Talk
Enterprise Explores
The Breakfast Grille Repeat
Dr Mohd Afzanizam of Bank Muamalat & Dr Ong Kian Ming of Taylor’s University discusses the impact of Trump’s tariffs on Malaysia.
Discovery Hour
An eclectic selection of BBC shows, curated with variety in mind.
Beyond the Ballot Box
In this conversation with Jomo Kwame Sundaram, we delve into the next stage of Malaysia's development, examining economic policy, structural challenges, and pathways for equitable growth.
Health & Living
How does the Ministry of Health decide what therapies are available in the public health system? And as more innovative and expensive therapies are developed, how do we balance cost with public need?
Top 5 at 5
Talkback Thursday
BBC World Service